Does anyone else see a potential for conflict of interest here?
According to articles found on the web, the National MS Society (based in the United States) owns a subsidiary that appears to function as a venture capital company, investing in drug start up companies and receiving royalties from drugs that make it to market.
Here's one article:
http://www.allbusiness.com/medicine-hea ... 687-1.html
Here's the website for the MS Society subsidiary, which is called "Fast Forward".
http://www.nationalmssociety.org/fast-f ... index.aspx
Here's one of several articles on the MS Society's Fast Forward website:
"MS Society teams with Merck KGaA on $19M R&D pact"
http://www.fiercebiotech.com/story/ms-s ... 2009-03-18
And here's a quote from an article about NMSS's Fast Forward (linked to below) that I found on the web:
"Fast Forward takes a venture capital-like approach to research collaborations"
www.nationalmssociety.org/fast-forward/ ... x?id=19232